A view from the Center

Deloitte Center
for Health Solutions

Filter by category or month:

Are micro-hospitals the next big trend in health care?

by Doug Beaudoin, Principal, Deloitte Consulting LLP

Micro-hospitals – small-scale inpatient facilities that are open 24 hours a day all year long and typically have between eight and 10 beds for observation and short-stay use –
are a growing trend in health care. Many health systems are using micro-hospitals to fill service gaps in markets where demand would not be able to support a traditional hospital.

Read more

The emerging Hispanic health care segment: What health plans should consider

by George Van Antwerp, Senior Manager, Deloitte Consulting LLP

Hispanics are a large and fast growing segment of the US population. As of 2014, there were over 55 million Hispanics in the US with the population projected to grow to 119 million by 2060. From a health care perspective, they’ve often been underrepresented and underserved. As the Hispanic population grows and ages from their current average age of 29,

Read more

EHRs, health IT, and the future of patient relationship management

by Mitch Morris, MD, Vice Chairman and Global Leader, Health Care Sector, Deloitte LLP

Back around 1990, I became aware of the potential of electronic health records (EHRs). The ability to use this technology to improve efficiency, effectiveness, quality, and safety felt like it was around the corner. At that point, I shifted my career away from medicine and toward enabling greater adoption of health information technology (IT), sure that the “vision” was near at hand.

Read more

A glimpse into the future: What technologies will allow consumers to get care at home?

by Sarah Thomas, Research Director, Deloitte Center for Health Solutions, Deloitte Services LP

Earlier this month, my husband and I went to see the new Star Trek movie. As usual, it was a lot of fun. It tells a great story that features moral dilemmas and heroism and presents a vision of the future. That future vision includes transportation, architecture, translation, space travel (of course), and even health care.

Read more

Public-private partnership is working to combat antimicrobial resistance

by Doug Beaudoin, Principal, Deloitte Consulting LLP

Antibiotic resistance has become one of our greatest public health threats. Antibiotics that were once effective have been used so widely and for so long that many of the pathogens have adapted, making the drugs less effective. The US Centers for Disease Control and Prevention (CDC) reports that at least 2 million people in the US become infected with antibiotic-resistant bacteria,

Read more

MACRA’s impact on biopharma: Pressing the accelerator on value-based care

by Jodi Reynolds, Principal, Life Sciences and Health Care, Deloitte Consulting LLP

You can’t read a health care publication these days without seeing MACRA as one of the headlines. There is no doubt that MACRA will be a transformative law, directly impacting how clinicians are paid under Medicare. But, will MACRA really impact other stakeholders – including biopharma companies? The answer is yes: the law reinforces where the industry is already headed with value-based care.

Read more